Abisola Idu, MS, MPH
“I apply well-established and innovative statistical methods to clinical and public health research. My objective is to support, challenge, or capture new findings that influence decisions that can improve health and health care, worldwide."
Abisola Idu, MS, MPH
Collaborative Biostatistician I, Kaiser Permanente Washington Health Research Institute
Abisola.Idu@kp.org
206-287-2893
Biography
Biostatistician Abisola Idu, MS, MPH, is interested in research that investigates the effectiveness and efficacy of treatment in pharmacoepidemiologic studies. She has a broad range of interest in research with a strong motivation to investigate the health challenges of malaria, obesity, cancer, heart disease, and maternal health.
Ms. Idu began her contributions to clinical and public health research through her academic training at the University of Texas Health Science Center, School of Public Health. She further got rigorous research experience by being a part of the leukemia, lymphoma, and cancer prevention research team at The University of Texas M.D. Anderson Cancer Center in 2015. She has been a biostatistician at Kaiser Permanente Washington Health Research Institute's Biostatistics Unit since 2018.
Ms. Idu looks forward to using her expertise in application of epidemiological principles and surveillance methodologies at KPWHRI. She has an in-depth knowledge of the ICH-GCP, FDA, IRB policies, regulations, and guidelines and plans to use her skills and background to implement epidemiologic study designs in clinical research studies.
Research interests and experience
-
Cancer
Efficacy and safety of therapies; association between genetic variability and survival outcomes
-
Obesity
Role of nutritional, psychological and lifestyle factors; obesity prevention and control
-
Heart Disease
Role of aging, nutritional and lifestyle factors; Intervention strategies for prevention and disease control
-
Maternal Health
Association between social, behavioral and clinical factors and maternal and infant outcomes
-
Malaria
Malaria prevention and control; development of vaccines; availability and accessibility to malaria treatment
-
Women's Health
-
Mental Health
-
Biostatistics
-
Social Determinants of Health
-
Vaccines & Infectious Diseases
-
Cardiovascular Health
Recent publications
Barnes DE, Balderson BH, Shulman L, Rosenberg DE, Matson TE, Mettert KD, Delaney K, King D, Adams K, Fleckenstein L, Peltz CB, Idu A, Larson EB, Yaffe K, Dublin S. The Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT) intervention: A personalized approach to dementia risk reduction. J Alzheimers Dis. 2024 Dec 3:13872877241296161. doi: 10.1177/13872877241296161. PubMed
Penfold RB, Idu AE, Coley RY, Cushing-Haugen KL, King D, Glass A, Phillips RC, Renz AD, Pabiniak CJ, Graham VF, Thompson EE, Ralston JD, Simon GE, Gonzalez ES, Myers KM, Beck A, Quintana LM, Runkle AJ, Rogers M, Foster DM, Clarke GN, Massimino S, Crawford PM, Cavese JA, Cordaro AR, Chavez LI, Kelleher KJ, Schwartz N, Jiner KR, Liu SB, Condrac S, Hilt RJ. Safer and targeted use of antipsychotics in youth: an embedded, pragmatic randomized trial. J Child Psychol Psychiatry. 2024 Oct 29. doi: 10.1111/jcpp.14059. Epub ahead of print]. PubMed
Mogk J, Idu AE, Bobb JF, Key D, Wong ES, Palazzo L, Stefanik-Guizlo K, King D, Beatty T, Dorsey CN, Caldeiro RM, Garza McWethy A, Glass JE. Prescription digital therapeutics for substance use disorder in primary care: mixed methods evaluation of a pilot implementation study. JMIR Form Res. 2024;8:e59088. doi: 10.2196/59088. PubMed
Bobb JF, Idu AE, Qiu H, Yu O, Boudreau DM, Wartko PD, Matthews AG, McCormack J, Lee AK, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Northrup TF, Braciszewski JM, Murphy MT, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Tsui JI, Burganowski RP, Weinstein ZM, Murphy SM, Hyun N, Bradley KA. Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial. Drug Alcohol Depend. 2024;261:111350. doi: 10.1016/j.drugalcdep.2024.111350. Epub 2024 Jun 10. PubMed
Rosenberg DE, Wu Y, Idu A, Greenwood-Hickman MA, McCurry SM, LaCroix AZ, Shaw PA. Historic cognitive function trajectories as predictors of sedentary behavior and physical activity in older adults. J Gerontol A Biol Sci Med Sci. 2024;79(7):glae125. doi: 10.1093/gerona/glae125. PubMed
Dublin S, Greenwood-Hickman MA, Karliner L, Hsu C, Coley RY, Colemon L, Carrasco A, King D, Grace A, Lee SJ, Walsh JME, Barrett T, Broussard J, Singh U, Idu A, Yaffe K, Boustani M, Barnes DE. The electronic health record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) Brain Health Trial: Protocol for an embedded, pragmatic clinical trial of a low-cost dementia detection algorithm. Contemp Clin Trials. 2023;135:107356. doi: 10.1016/j.cct.2023.107356. Epub 2023 Oct 17. PubMed
Research
Increasing opioid use disorder treatment in primary care
A trial led by KPWHRI researchers found that adding nurse care managers helped more people get needed treatment.
Research
Dementia risk screening tool shows promise
In a new study, a tool to help discover undiagnosed dementia performed well in 2 separate health systems.
Research
New findings on treating hypertension in pregnancy
A study led by Dr. Sascha Dublin finds similar outcomes for 3 hypertension medications, filling an evidence gap.
COVID-19
Greater infection risks linked to COVID-19 disparities
New work by Susan Shortreed, PhD, finds infection risks drive worse outcomes for some racial and ethnic groups.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.